Disrupting process development in Asia
February 28, Tokyo, Japan. This week, GoSilico met the Asian Downstream community. From February 26 to 28, BioProcess International Asia in Tokyo, Japan, brought together global expertise in the development and production of biopharmaceutical products. Speakers from around the world presented case studies and best practices. In particular, the talks of major Asian companies were very exciting. Well-known companies such as Takeda, Chugai and new champions such as Innovent gave insights into their development and manufacturing processes of biopharmaceuticals for the global market.
"I was very impressed with the forward thinking and consistent approach of emerging Asian companies. In particular, I was fascinated by their efforts to reduce the costs of new therapies, as they allow broader patient access in countries such as China. ", Says Thiemo Huuk. Due to the international atmosphere, the mood was very stimulating and led to very interesting results panel discussions. GoSilico was prominently described as "the young company that disrupts process development through simulation". Thank you for pointing this out to the Asian community, Günter Jagschies (Senior Director, GE).